The role of the amyloid protein precursor (APP) in Alzheimer's disease: Does the normal function of APP explain the topography of neurodegeneration?

Neurochemical Research

Volumn 23, Issue 5, 1998, Pages 795-806

  Small, David H ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Alzheimer; Amyloid; Dementia; Neurite; Plaque; Proteoglycan

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ARTICLE; HUMAN; NERVE DEGENERATION; NEURITE; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; SENILE PLAQUE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 21; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NERVE DEGENERATION; NEUROTOXINS; WOUND HEALING;

EID: 0031898770     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022471729291     Document Type: Article

References (167)

1. Schoenberg, B. S., Kohmen, E., and Ohazaki, H. 1987. Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann. Neurol. 22:724-729.
2. Alzheimer, A. 1907. Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und Psychisch-gerichtliche Medizin 64:146-148.
3. Masliah, E., Mallory, M., Hansen, L., Alford, M., DeTeresa, R., Terry, R., Baudier, J., and Saitoh, T. 1992. Localization of amyloid precursor protein in GAP-43 immunoreactive aberrant sprouting neuntes in Alzheimer's disease. Brain Res. 574:312-316.
4. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., and Beyreuther, K. 1985. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82:4245-4249.
5. Glenner, G. G., and Wong, C. W. 1984. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:885-890.
6. Trojanowski, J. Q., and Lee, V. M. 1994. Paired helical filament tau in Alzheimer's disease. The kinase connection. Am. J. Pathol. 144:449-453.
7. Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., Multhaup, G., Beyreuther, K., and Müller-Hill, B. 1987. The precursor of Alzheimer's disease A4 protein resembles a cell surface receptor. Nature 325:733-736.
8. Goldgaber, D., Lerman, M. I., McBride, O. W., Saffiotti, U., and Gajdusek, D. C. 1987. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235:877-880.
9. Robakis, N. K., Wisniewski, H. M., Jenkins, E. C., Devine-Gage, E. A., Houck, G. E., Yao, X. L., Ramakrishna, N., Wolfe, G., Silverman, W. P., and Brown, W. T. 1987. Chromosome 21q21 sublocalization of gene encoding beta-amyloid peptide in cerebral vessels and neuritic (senile) plaques of people with Alzheimer's disease and Down syndrome. Lancet 1:384-385.
10. Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St. George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., and Neve, R. L. 1987. Amyloid β protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer's locus. Science 235:880-884.
11. Yoshikai, S., Sasaki, H., Doh-ura, K., Furuya, H., and Sakaki, Y. 1990. Genomic organization of the human amyloid beta-protein precursor gene. Gene 87:257-263.
12. Kitaguchi, N., Takahashi, Y., Tokushima, Y., Shiojiri, S., and Ito, H. 1988. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 331:530-532.
13. Ponte, P., Gonzalez-DeWhitt, P., Schilling, J., Miller, J., Hsu, D., Greenberg, B., David, K., Wallace, W., Lieberburg, I., Fuller, F., and Cordell, B. 1988. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 331: 525-527.
14. Tanzi, R. E., McClatchey, A. I., Lamperti, E. D., Villa-Komaroff, L., Gusella, J. F., and Neve, R. L. 1988. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331:528-530.
15. De Sauvage F., and Octave, J. 1989. A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein. Science 245:651-653.
16. Golde, T. E., Estus, S., Usiak, M., Younkin, L. H., and Younkin, S. G. 1990. Expression of β amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR. Neuron 4:253-267.
17. Jacobsen, J. S., Muenkel, H. A., Blume, A. J., and Vitek, M. P. 1991. A novel species-specific RNA related to alternatively spliced amyloid precursor protein mRNAs. Neurobiol. Aging 12: 575-583.
18. Evin, G., Beyreuther, K., and Masters, C. L. 1994. Alzheimer's disease amyloid precursor protein (AβPP): proteolytic processing, secretases and βA4 amyloid production. Amyloid 1:263-280.
19. Esch, F. S., Keim, P. S., Beattle, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., and Ward, P. J. (1990) Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248:1122-1124.
20. Siman, R., Card, J. P., and Davis, L. G. 1990. Proteolytic processing of β-amyloid precursor by calpain I. J. Neurosci. 10: 2400-2411.
21. Allsop D., Yamamoto T., Kametani, F., Miyazaki, N., and Ishii, T. 1991. Alzheimer amyloid β/A4 peptide binding sites and a possible "APP secretase" activity associated with rat brain cortical membranes. Brain Res. 551:1-9.
22. Small, D. H., Moir, R. D., Fuller, S. J., Michaelson, S., Bush, A. I., Li, Q. X., Milward, E., Hilbich, C., Weidemann, A., Beyreuther, K., and Masters, C. L. 1991. A protease activity associated with acetylcholinesterase releases the membrane-bound form of the amyloid protein precursor of Alzheimer's disease. Biochemistry 30:10795-10799.
23. Tagawa, K., Kunishita, T., Maruyama, K., Yoshikawa, K., Kominami, E., Tsuchiya, T., Suzuki, K., Tabira, T., Sugita, H., and Ishiura, S. 1991. Alzheimer's disease amyloid β-clipping enzyme (APP secretase): identification, purification and characterization of the enzyme. Biochem. Biophys. Res. Commun. 177:377-387.
24. Kojima, S., and Omori, M. 1992. Two-way cleavage of β-amyloid protein precursor by multicatalytic proteinase. FEBS Lett. 304:57-60.
25. Miyazaki, K., Hasegawa, M., Funahashi, K., and Umeda, M. 1993. A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. Nature 362:839-841.
26. Marks, N., Berg, M. J., Chi, L. M., Choi, J., Durrie, R., Swistok, J., Makofske, R. C., Danho, W., and Sapirstein, V. S. 1994. Hydrolysis of amyloid precursor protein-derived peptides by cysteine proteinases and extracts of rat brain clathrin-coated vesicles. Peptides 15:175-182.
27. Golde, T. E., Estus, S., Younkin, L. H., Selkoe, D. J., and Younkin, S. G. 1992. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255:728-730.
28. Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, L, Koo, E. H., Schenk, D., Teplow, D. B., and Selkoe, D. L. 1992. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359:322-325.
29. Estus, S., Golde, T. E., Kunishita, T., Blades, D., Lowery, D., Eisen, M., Usiak, M., Qu, X., Tabira, T., Greenberg, B. D., and Younkin, S. G. 1992. Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 255: 726-728.
30. Snyder, S. W., Ladror, U.S., Wade, W. S., Wang, G. T., Barrett, L. W., Matayoshi, E. D., Huffaker, H. J., Krafft, G. A., and Holzman, T. F. 1994. Amyloid-beta aggregations - selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys. J. 67:1216-1228.
31. Blanquet V., Goldgaber, D., Turleau, C., Créau-Goldberg, N., Delabar, J., Sinet, P. M., Roudier, M., and de Grouchy, J. 1987. The β amyloid protein (AD-AP) cDNA hybridizes in normal and Alzheimer individuals near the interface of 21q21 and q22.1. Ann. Genet. 30:68-69.
32. Zabel, B. U., Salbaum, J. M., Multhaup, G., Masters, C. L., Bohl, J., and Beyreuther, K. 1987. Sublocalization of the gene for the precursor of Alzheimer's disease amyloid A4 protein on chromosome 21. Cytogenet. Cell Genet. 46:725-726.
33. Wisniewski, K. E., Wisniewski, H. M., and Wen, G. Y. 1985. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17:359-365.
34. Mann, D. M. A. 1988. The pathological associations between Down syndrome and Alzheimer's disease. Mech. Age Dev. 43: 99-136.
35. Rumble, B., Retallack, R., Hilbich, C., Simms, G., Multhaup, G., Martins, R., Hockey, A., Montgomery, P., Beyreuther, K., and Masters, C. L. 1989. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N. Engl. J. Med. 320:1446-1452.
36. Tanzi, R. E., 1996. Neuropathology in the Down's syndrome brain. Nature Med. 2:11-12.
37. Goate, A., Chartier-Harlin, M., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., Mant, R., Newton, P., Rooke, K., Roques, P., Talbot, C., Pericak-Vance, M., Roses, A., Williamson, R., Rossor, M., Owen, M., and Hardy, J. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706.
38. Naruse, S., Igarashi, S., Kobayashi, J., Aoki, K., Inuzuka, T., Kaneko, K., Shimizu, T., Iihara, K., Kojima, T., Miyatake, T., and Tsuji, S. 1991. Mis-sense mutation V → I in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet 337:978-979.
39. Murrell, J., Farlow, M., Ghetti, B., and Benson, M. D. 1991. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254:97-99.
40. Chartier-Harlin, M., Crawford, F., Hamandi, K., Mullan, M., Goate, A., Hardy, J., Backhovens, H., Martin, J., and van Broeckhoven, C. 1991. Screening for the β-amyloid precursor protein mutation (APP717: Val → Ile) in extended pedigrees with early onset Alzheimer's disease. Neurosci. Lett. 129:134-135.
41. Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., and Mullan, M. 1991. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 353:844-846.
42. Tanzi, R., and Hyman, B. T., 1991. Alzheimer's mutation. Nature 350:564.
43. Suzuki, N., Cheung, T. T., Cai, X. D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., and Younkin, S. G. 1994. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264: 1336-1340.
44. Cai., X. D., Golde, T. E., and Younkin, S. G. 1993. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259:514-516.
45. Johnston, J., O'Neill, C., Lannfelt, L., Winblad, B., and Cowburn, R. F. 1994. The significance of the Swedish APP670/671 mutation for the development of Alzheimer's disease amyloidosis. Neurochem. Int. 25:73-80.
46. Johnston, J. A., Cowburn, R. F., Norgren, S., Wiehager, B., Venizelos, N., Winblad, B., Vigo Pelfrey, C., Schenk, D., Lannfelt, L., and O'Neill, C. 1994. Increased β-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation. FEBS Lett. 354:274-278.
47. Martin, B. L., Schrader-Fischer, G., Busciglio, J., Duke, M., Paganetti, P., and Yankner, B. A. 1995. Intracellular accumulation of β-amyloid in cells expressing the Swedish mutant amyloid precursor protein. J. Biol. Chem. 270:26727-26730.
48. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guido, T., Hagopian, S., Johnson-Wood, K., Khan, K., Lee, M., Leibowitz, P., Lieberburg, I., Little, S., Masliah, E., McConlogue, L., Montoya-Zavala, M., Mucke, L., Paganini, L., Penniman, E., Power, M., Schenk, D., Seubert, P., Snyder, B., Soriano, F., Tan, H., Vitale, J., Wadsworth, S., Wolozin, B., and Zhao, J. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527.
49. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. S., and Cole, G. 1996. Correlative memory deficits, A-beta elevation, and amyloid plaques in transgenic mice. Science. 274:99-102.
50. Tanzi, R. E., Vaula, G., Romano, D. M., Mortilla, M., Huang, T. L., Tupler, R. G., Wasco, W., Hyman, B. T., Haines, J. L., Jenkins, B. J., Kalaitsidaki, M., Warren, A. C., McInnis, M. G., Antonarakis, S. E., Karlinsky, H., Percy, M. E., Connor, L., Growdon, J., Crapper-Mclachlan, D. R., Gusella, J. F., and St. George-Hyslop, P. H. 1992. Assessment of amyloid β protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am. J. Hum. Genet. 51:273-282.
51. Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J. F., Bruni, A. C., Montesi, M. P., Sorbi, S., Rainero, I., Pinnessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R. J., Wasco, W., Da Silva, H. A. R., Haines, J. L., Pericak-Vance, M. A., Tanzi, R. E., Roses, A. D., Fraser, P. E., Rommens, J. M., and St. George Hyslop, P. H. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760.
52. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C., Jondro, P. D., Schmidt, S. D., Wang, K., Crowley, A. C., Fu, Y.-H., Guenette, S. Y., Galas, D., Nemens, E., Wijsman, E. M., Bird, T. D., Schellenberg, G. D., and Tanzi, R. E. 1995. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-977.
53. Cook, D. G., Sung, J. C., Golde, T. E., Felsenstein, K. M., Wojcz Yk, B. S., Tanzi, R. E., Trojanowski, J. Q., Lee, V. M. Y., and Doms, R. W. 1996. Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. Proc. Natl. Acad. Sci. USA 93:9223-9228.
54. Kovacs, D. M., Fausett, H. J., Page, K. J., Kim, T. W., Moir, R. D., Merriam, D. E., Hollister, R. D., Hallmark, O. G., Mancini, R., Felsenstein, K. M., Hyman, B. T., Tanzi, R. E., and Wasco, W. 1996. Alzheimer associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Med. 2:224-229.
55. Haass, C., Walter, J., Grunberg, P., George-Hyslop, P., Selkoe, D., Pesold, B., and Capell, A. 1996. Expression of the presenilin proteins PS-1 and PS-2 in tissue culture cells. Neurobiol. Aging 17:S38.
56. Thinakaran, G., Borcehlt, D., Lee, M., Slunt, H., Spitzer, L., Kim, G., Ratovitsky, T., Davenport, F., Nordstedt, C., Seeger, M., Hardy, J., Levey, A. I., Gandy, S. E., Jenkins, N. A., Copeland, N. G., Price, D. L., and Sisodia, S. S. 1996. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17:181-190.
57. Levitan, D., and Greenwald, I. 1995. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377:351-354.
58. Campion, D., Flaman, J.-M., Brice, A., Mannequin, D., Dubois, B., Martin, C., Moreau, V., Charbonnier, F., Didierjean, O., Tardieu, S., Penet, C., Puel, M., Pasquier, F., Ledoze, F., Bellis, G., Calenda, A., Heilig, R., Martinez, M., Mallet, J., Bellis, M., Clerget-Darpoux, F., Agid, Y., and Frebourg, T. 1995. Mutations of the presenilin 1 gene in families with early-onset Alzheimer's disease. Hum. Mol. Genet. 4:2373-2377.
59. Clark, R. F., Hutton, M., Fuldner, R. A., Froelich, S., Karran, E., Talbot, C., and 57 other authors. 1995. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat. Genet. 11:219-222.
60. Boteva, K., Vitek, M., Mitsuda, H., de Silva, H., P. T., Xu, P. T., Small, G., and Gilbert, J. R. 1996. Mutation analysis of presenilin 1 gene in Alzheimer's disease. Lancet 347:130-131.
61. Cruts, M., Hendriks, L., and Van Broeckhoven, C. 1996. The presenilin genes: a new gene family involved in Alzheimer's disease pathology. Hum. Mol. Genet. 5:1449-1455.
62. Hutton, M., Busfield, F., Wragg, M., Crook, R., Perez-Tur, J., Clark, R. F., Prihar, G., Talbat, C., Phillips, H., Wright, K., Baker, M., Lendon, C., Duff, K., Martinez, A., Houlden, H., Nichols, A., Karran, E., Roberts, G., Venter, J. C., Adams, M. D., Cline, R. T., Phillips, C. A., Fuldner, R. A., Hardy, J., and Goate, A. 1996. Complete analysis of the presenilin 1 gene in families with early-onset Alzheimer's disease. Neuroreport 7: 801-805.
63. Perez-Tur, J., Froelich, S., Prihar, G., Crook, R., Baker, M., Duff, K., Wragg, M., Busfield, F., Lendon, C., Clark, R. F., Roques, P., Fuldner, R. A., Johnston, J., Cowburn, R., Forsell, C., Axelman, K., Lilius, L., Houlden, H., Karran, E., Roberts, G. W., Rossor, M., Adams, M. D., Hardy, J., Goate, A., Lannfelt, L., and Hutton, M. 1995. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7:297-301.
64. Wasco, W., Pettingell, W. P., Jondro, P. D., Schmidt, S. D., Gurubhagavatula, S., Rodes, L., DiBlasi, T., Romano, D. M., Guenette, S. Y., Kovacs, D. M., Growdon, J. H., and Tanzi, R. E. 1995. Familial Alzheimer's chromosome 14 mutations. Nature Med. 1:848.
65. Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lehad, E., Tiitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R. E., Wasco, W., Lannfelt, L., Selkoe, D., and Younkin, S. 1996. Aβ42(43) is increased in vivo by the PS1/2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2:864-870.
66. Mahley, R. W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622-630.
67. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M. A., Enghild, J., Salvesen, G. S., and Roses, A. D. 1993. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90:1977-1981.
68. Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., and Roses, A. D. 1993. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90:9649-9653.
69. Ma, J., Yee, A., Brewer, H. B., Das, S., and Potter, H. 1994. Amyloid-associated proteins α1-antichymotrypsin and apolipo-protein E promote assembly of Alzheimer β-protein into filaments. Nature 372:92-94.
70. LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., and Frail, D. E. 1994. Isoform-specific binding of apolipoprotein E to beta-amyloid. J. Biol. Chem. 269:23403-23406.
71. Zhou, Z., Smith, J. D., Greengard, P., and Gandy, S. 1996. Alzheimer amyloid-β peptide forms denaturant-resistant complex with type e3 but not type e4 isoform of native apolipoprotein E. Mol. Med. 2:175-180.
72. Yang, D.-S., Smith, J. D., Zhou, Z., Gandy, S. E., and Martins, R. N. 1997. Characterization of the binding of amyloid-β peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma. J. Neurochem. 68: 721-725.
73. Isoe, K., Urakami, K., Sato, K., and Takahashi, K. 1996. Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia. Acta Neurol. Scand. 94:326-328.
74. Kehoe, P., Williams, J., Holmans, P., Liddell, M., Lovestone, S., Holmes, C., Powell, J., Neal, J., Wilcock, G., and Owen, M. J. 1996. Association between a PS-1 intronic polymorphism and late onset Alzheimers. Neuroreport 7:2155-2158.
75. Poduslo, S. E., Herring, K., and Neal, M. 1996. A presenilin 1 mutation in an early onset Alzheimer's family - no association with presenilin 2. Neuroreport 7:2018-2020.
76. Sherrington, R., Froelich, S., Sorbi, S., Campion, D., Chi, H., Rogaeva, E. A., Levesque, G., Rogaev, E. I., Lin, C., Liang, Y., Ikeda, M., Mar, L., Brice, A., Agid, Y., Percy, M. E., Clergetdarpoux, F., Piacentini, S., Marcon, G., Nacmias, B., Amaducci, L., Frebourg, T., Lannfelt, L., Rommens, J. M., and St. George Hyslop, P. H. 1996. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum. Mol. Genet. 5:985-988.
77. Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L., and Neve, R. L. 1989. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245:417-420.
78. Frautschy, S. A., Baird, A., and Cole, G. M. 1991. Effects of injected Alzheimer β-amyloid cores in rat brain. Proc. Natl. Acad. Sci. USA 88:8362-8366.
79. Kowall, N. W., Beal, M. F., Busciglio, J., Duffy, L. K., and Yankner, B. A. 1991. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA 88:7247-7251.
80. Pike, C. J., Walencewicz, A. J., Glabe, C. G., and Cotman, C. W. 1991. Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures. Eur. J. Pharmacol. 207:367-368.
81. Pike, C. J., Walencewicz, A. J., Glabe, C. G., and Cotman, C. W. 1991. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:311-314.
82. Howlett, D. R., Jennings, K. H., Lee, D. C., Clark, M. S. G., Brown, F., Wetzel, R., Wood, S. J., Camilleri, P., and Roberts, G. W. 1995. Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration 4:23-32.
83. Yankner, B. A., Duffy, L. K., and Kirschner, D. A. 1990. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250:279-282.
84. Pike, C. J., Walencewicz-Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., and Cotman, C. W. 1995. Structure-activity analyses of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64:253-265.
85. Joslin, G., Krause, J. E., Hershey, A. D., Adams, S. P., Fallon, R. J., and Perlmutter, D. H. 1991. Amyloid-β peptide, substance P, and bombesin bind to the serpin-enzyme complex receptor. J. Biol. Chem. 266:21897-21902.
86. Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H. J., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., and Schmidt, A. M. 1996. RAGE and yloid-beta peptide neurotoxicity in Alzheimer's disease Nature. 382:685-691.
87. Hardy, J. A., and Higgins, G. A. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science 256:184-185.
88. Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., and Rydel, R. E. 1992. β-Amyloid peptides destablize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:376-389.
89. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16:409-414.
90. Mattson, M. P., Tomaselli, K. J., and Rydel, R. E. 1993. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res. 621:35-49.
91. Davidson, R. M., Shajenko, L., and Donta, T. S. 1994. Amyloid β-peptide (AβP) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells. Brain Res. 643:324-327.
92. 2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62:372-375.
93. Ueda, K., Shinohara, S., Yagami, T., Asakura, K., and Kawasaki, K. 1997. Amyloid β protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals. J. Neurochem. 68:265-271.
94. 2+ homeostasis and cell death. J. Neurosci. 15:6239-6249.
95. 2+ influx. J. Neurochem. 65:1061-1068.
96. Behl, C., Davis, J. B., Lesley, R., and Schubert, D. 1994. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77: 817-827.
97. Butterfleld, D. A., Hensley, K., Harris, M., Mattson, M. P., and Carney, J. 1994. β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200:710-715.
98. Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., and Butterfield, D. A. 1994. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 91:3270-4.
99. Goodman, Y., and Mattson, M. P. 1994. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128: 1-12.
100. Café, C., Torri, C., Bertorelli, L., Angeretti, N., Lucca, E., Forloni, G., and Marzatico, F. 1996. Oxidative stress after acute and chronic application of β-amyloid fragment 25-35 in cortical cultures. Neurosci. Lett. 203:61-65.
101. Bruce, A. J., Malfroy, B., and Baudry, M. 1996. β-amyloid toxicity in organotypic hippocampal cultures - protection by EUK-8, a synthetic catalytic free radical scavenger. Proc. Natl. Acad. Sci. USA 93:2312-2316.
102. Arvin, B., Neville, L. F., Barone, F. C., and Feuerstein, G. Z. 1996. The role of inflammation and cytokines in brain injury. Neurosci. Biobehav. Rev. 20:445-452.
103. Finch, C. E., and Marchalonis, J. J. 1996. Evolutionary perspectives on amyloid and inflammatory features of Alzheimer disease. Neurobiol. Aging. 17:809-815.
104. McGeer, P. L., Schulzer, M., and McGeer, E. G. 1996. Arthritis and anti-inflammatory agents as possible protective factors for zheimer's disease - a review of 17 epidemiologic studies. Neurology 47:425-432.
105. Pasinetti, G. M. 1996. Inflammatory mechanisms in neurodegeneration and Alzheimer's disease - the role of the complement system. Neurobiol. Aging. 17:707-716.
106. Gitter, B. D., Cox, L. M., Rydel, R. E., and May, P. C. 1995. Amyloid β peptide potentiates cytokine secretion by interleukin-1-β-activated human astrocytoma cells. Proc. Natl. Acad. Sci. USA 92:10738-10741.
107. Elkhoury, J., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., and Loike, J. D. 1996. Scavenger receptor-mediated adhesion of microglia to beta-amyloid. Nature. 382:716-719.
108. Paresce, D. M., Ghosh, R. N., and Maxfield F. R. 1996. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron. 17:553-565.
109. Small, D. H., Nurcombe, V., Moir, R., Michaelson, S., Monard, D., Beyreuther, K., and Masters, C. L. 1992. Association and release of the amyloid protein precursor of Alzheimer's disease from chick brain extracellular matrix. J. Neurosci. 12:4143-4150.
110. Shivers, B. D., Hilbich, C., Multhaup, G., Salbaum, M., Beyreuther, K., and Seeburg, P. H. 1988. Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J. 7:1365-1370.
111. Doyle, E., Bruce, M. T., Breen, K. C., Smith, D. C., Anderton, B., and Regan, C. M. 1990. Intraventricular infusions of antibodies to amyloid-β-protein precursor impair the acquisition of a passive avoidance response in the rat. Neurosci. Lett. 115:97-102.
112. Schubert, W., Prior, R., Weidemann, A., Dircksen, H., Multhaup, G., Masters, C. L., and Beyreuther, K. 1991. Localization of Alzheimer βA4 amyloid precursor protein at central and peripheral synaptic sites. Brain Res. 563:184-194.
113. Moya, K. L., Confaloni, A. M., and Allinquant, B. 1994. In vivo neuronal synthesis and axonal transport of Kunitz protease inhibitor (KPI)-containing forms of the amyloid precursor protein. J. Neurochem. 63:1971-1974.
114. Arai, H., Higuchi, S., Matsushita, S., Yuzuriha, T., Trajanowski, J. Q., and Lee V. M. Y. 1994. Expression of β- amyloid precursor protein in the developing human spinal cord. Brain Res. 642:132-136.
115. Salbaum, J. M., and Ruddle, F. H. 1994. Embryonic expression pattern of amyloid protein precursor suggests a role in differentiation of specific subsets of neurons. J. Exp. Zool. 269:116-127.
116. König, G., Mönning, U., Czech, C., Prior, R., Banati, R., Schreiter-Gasser, U., Bauer, J., Masters, C. L., and Beyreuther, K. 1992. Identification and differential expression of a novel alternative splice isoform of the beta A4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells. J. Biol. Chem. 267:10804-10809.
117. Fukuchi, K. I., Deeb, S. S., Kamino, K., Ogburn, C. E., Snow, A. D., Sekiguchi, R. T., Wight, T. N., Piusson, H., and Martin, G. M. 1992. Increased expression of β-amyloid protein precursor and microtubule-associated protein T during the differentiation of murine embryonal carcinoma cells. J. Neurochem. 58:1863-1873.
118. Hung, A. Y., Koo, E. H., Haass, C., and Selkoe, D. J. 1992. Increased expression of beta-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage. Proc. Natl. Acad. Sci. USA 89:9439-43.
119. Clarris, H. J., Nurcombe, V., Small, D. H., Beyreuther, K., and Masters, C. L. 1994. Secretion of nerve growth factor from septum stimulates neurite outgrowth and release of the amyloid protein precursor of Alzheimer's disease from hippocampal explants. J. Neurosci. Res. 38:248-258.
120. Refolo, L. M., Salton, S. R. J., Anderson, J. P., Mehta, P., and Robakis, N. K. 1989. Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from 12 cell cultures. Biochem. Biophys. Res. Commun. 164: 664-670.
121. Clams, H. J., Key, B., Beyreuther, K., Masters, C. L., and Small, D. H. 1995. Expression of the amyloid protein precursor of Alzheimer's disease in the developing rat olfactory system. Dev. Brain Res. 88:87-95.
122. Milward, E. A., Papadopoulos, R., Fuller, S. J., Moir, R. D., Small, D., Beyreuther, K., and Masters, C. L. 1992. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron. 9: 129-137.
123. Whitson, J. S., Glabe, C. G., Shintani, E., Abcar, A., and Cotman, C. W. 1990. β-Amyloid protein promotes neuritic branching in hippocampal cultures. Neurosci. Lett. 110:319-324.
124. Yankner, B. A., Caceres, A., and Duffy, L. K. 1990. Nerve growth factor potentiates the neurotoxicity of β amyloid. Proc. Natl. Acad. Sci. USA 87:9020-9023.
125. Mattson, M. P. 1994. Secreted forms of β-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J. Neurobiol. 25:439-450.
126. Jin, L. W., Ninomiya, H., Roch, J. M., Schubert, D., Masliah, E., Otero, D. A., and Saitoh, T. 1994. Peptides containing the RERMS sequence of amyloid β/A4 protein precursor bind cell surface and promote neurite extension. J. Neurosci. 14:5461-5470.
127. Small, D. H., Nurcombe, V., Reed, G., Clarris, H., Moir, R., Beyreuther, K., and Masters, C. L. 1994. A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J. Neurosci. 14: 2117-2127.
128. Williamson, T. G., Nurcombe, V., Beyreuther, K., Masters, C. L., and Small, D. H. 1995. Affinity purification of proteoglycans that bind the amyloid protein precursor of Alzheimer's disease. J. Neurochem. 65:2201-2208.
129. Williamson, T. G., Mok, S. S., Henry, A., Cappai, R., Lander, A., Nurcombe, V., Beyreuther, K., Masters, C. L., and Small, D. H. 1996. Secreted glypican binds to the amyloid protein precursor (APP) of Alzheimer's disease and inhibits APP-induced neurite outgrowth. J. Biol. Chem. 271:31215-31221.
130. Ninomiya, H., Roch, J. M., Jin, L. W., and Saitoh, T. 1994. Secreted form of amyloid beta/A4 protein precursor (APP) binds to two distinct APP binding sites on rat B103 neuron-like cells through two different domains, but only one site is involved in neuritotrophic activity. J. Neurochem. 63:495-500.
131. Furukawa, K., Sopher, B. L., Rydel, R. E., Begley, J. G., Pham, D. G., Martin, G. M., Fox, M., and Mattson, M. P. 1996. Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J. Neurochem. 67:1882-1896.
132. + channels and suppression of neuronal activity by secreted β-amyloid precursor protein. Nature 379:74-78.
133. Mattson, M. P. 1988. Neurotransmitters in the regulation of neuronal cytoarchitecture. Brain Res. Rev. 13:179-212.
134. Salbaum, J. M., Weidemann, A., Lemaire, H., Masters, C. L., and Beyreuther, K. 1988. The promoter of Alzheimer's disease amyloid A4 precursor gene. EMBO J. 7:2807-2813.
135. Bush, A. I., Martins, R. N., Rumble, B., Moir, R., Fuller, S., Milward, E., Currie, J., Ames, D., Weidemann, A., Fischer, P., Multhaup, G., Beyreuther, K., and Masters, C. L. 1990. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J. Biol. Chem. 265, 15977-15983.
136. Van Nostrand, W. E., and Cunningham, D. D. 1987. Purification of protease nexin II from human fibroblasts. J. Biol. Chem. 262: 8508-8514.
137. Li, Q. X., Berndt, M. C., Bush, A. I., Rumble, B., Mackenzie, I., Friedhuber, A., Beyreuther, K., and Masters, C. L. 1994. Membrane-associated forms of the βA4 amyloid protein precursor of Alzheimer's disease in human platelets and brain: surface expression on the activated human platelet. Blood 84:133-142.
138. Roch J. M., Sundsmo, M. P., Otero, D. A., Refolo, L. M., Robakis, N. K., and Saitoh, T. 1992. Bacterial expression, purification, and functional mapping of amyloid β/A4 precursor. J. Biol. Chem. 267:2214-2221.
139. Abe, K., Tanzi, R. E., and Kogure, K. 1991. Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci. Lett. 125:172-174.
140. Banati, R. B., Gehrmann, J., Lannesvieira, J., Wekerle, H., and Kreutzberg, G. W. 1995. Inflammatory reaction in experimental autoimmune encephalomyelitis (EAE) is accompanied by a microglial expression of the beta-A4-amyloid precursor protein (APP). Glia 14:209-215.
141. Sherriff, F. E., Bridges, L. R., Gentleman, S. M., Sivaloganathan, S., and Wilson S. 1994. Markers of axonal injury in post mortem human brain. Acta Neuropathol. 88:433-439.
142. Blumbergs, P. C., Scott, G., Manavis, J., Wainwright, H., and Simpson, D. A. 1995. Topography of axonal injury as defined by amyloid precursor protein and the sector scoring method in mild and severe closed head injury. J. Neurotrauma 12:565-572.
143. Lewis, S. B., Finnie, J. W., Blumbergs, P. C., Scott, G., Manavis, J., Brown, C., Reilly, P. L., Jones, N. R., and Mclean, A. J. 1996. A head impact model of early axonal injury in the sheep. J. Neurotrauma 13:505-514.
144. Ichihara, N., Wu, J., Chui, D. H., Yamazaki, K., Wakabayashi, T., and Kikuchi, T. 1995. Axonal degeneration promotes abnormal accumulation of amyloid β-protein in ascending gracile tract of gracile axonal dystrophy (GAD) mouse. Brain Res 695:173-178.
145. Ahlgren, S., Li, G. L., and Olsson, Y. 1996. Accumulation of beta-amyloid precursor protein and ubiquitin in axons after spinal cord trauma in humans - immunohistochemical observations on autopsy material. Acta Neuropathol. 92:49-55.
146. Chauvet, N., Apert, C., Dumoulin, A., Epelbaum, J., and Alonso, G. 1997. MAB22C11 antibody to amyloid precursor protein recognizes a protein associated with specific astroglial cells of the rat central nervous system characterized by their capacity to support axonal outgrowth. J. Comp. Neurol. 377:550-564.
147. Mann, D. M. A., Yates, P. O., Marcyniuk, B., and Ravindra, C. R. 1986. The topography of plaques and tangles in Down's syndrome patients of different ages. Neuropathol. Appl. Neurobiol. 12:447-457.
148. Bush, A. I., Pettingell, W. H., Multhaup, G., de Paradis, M., Vonsattel, J. P., Gusella, J. F., Beyreuther, K., Masters, C. L., and Tanzi, R. E. 1994. Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science 265:1464-1467.
149. Nicoll, J. A. R., Roberts, G. W., and Graham, D. I. 1995. Apolipoprotein E. epsilon-4 allele is associated with deposition of amyloid beta-protein following head injury. Nature Med. 1:135-137.
150. Schwab, M. E., Kapfhammer, J. P., and Bandtlow, C. W. 1993. Inhibitors of neunte outgrowth. Ann. Rev. Neurosci. 16:565-595.
151. Li, M., Shibata, A., Li, C. M., Braun, P. E., Mckerracher, L., Roder, J., Kater, S. B., and David, S. 1996. Myelin-associated glycoprotein inhibits neurite/axon growth and causes growth cone collapse. J. Neurosci. Res. 46:404-414.
152. Small, D. H., Mok, S. S., Williamson, T. G., and Nurcombe, V. 1996. The role of proteoglycans in neural development, regeneration and the ageing brain. J. Neurochem. 67:889-899.
153. Cohan, C. S., Connor, J. A., and Kater, S. B. 1987. Electrically and chemically mediated increase in intracellular calcium in neuronal growth cones. J. Neurosci. 7:3588-3599.
154. Byrne, J. H. 1987. Cellular analysis of associative learning. Physiol. Rev. 67:329-439.
155. Bailey, C. H., and Chen, M. 1983. Morphological basis of long-term habituation and sensitization in Aplysia. Science 220:91-93.
156. Moulton, D. C. 1974. Dynamics of cell population in the olfactory epithelium. Ann N.Y. Acad. Sci. 237:52-61.
157. Masliah, E., Fagan, A. M., Terry, R. D., DeTeresa, R., Mallory, M., Gage, F. H. 1991. Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat. Exp. Neurol. 113:131-142.
158. Dawirs, R. R., Teuchert-Noodt, G., Kacza, J. 1992. Naturally occurring degrading events in axon terminals of the dentate gyrus and stratum lucidum in the spiny mouse (Acomys cahirinus) during maturation, adulthood and aging. Dev. Neurosci. 14:210-220.
159. Braak, H., and Braak, E. 1996. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol. 92:197-201.
160. Esiri, M. M., and Wilcock, G. K. 1984. The olfactory bulbs in Alzheimer's disease. J. Neurol. Neurosurg. Psychiat. 47:56-60.
161. Ohm, T. G., and Braak, H. 1987. Olfactory bulb changes in Alzheimer's disease. Acta Neuropathol. 73:365-369.
162. Snow, A. D., Mar, H., Nochlin, D., Kimata, K., Kato, M., Suzuki, S., Hassell, J., and Wight, T. N. 1988. The presence of paran sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133: 456-463.
163. Rosenblatt, D. E., Geula, C., and Mesulam, M. M. 1989. Protease nexin I immunostaining in Alzheimer's disease. Ann. Neurol. 26: 628-634.
164. Gomez-Pinilla, F., Cummings, B. J., and Cotman, C. W. 1990. Induction of basic fibroblast growth factor in Alzheimer's disease pathology. Neuroreport 1:211-214.
165. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., and Ikeda, K. 1991. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:163-166.
166. Perlmutter, L. S., Barron, E., Saperia, D., and Chui, H. C. 1991. Association between vascular basement membrane components and the lesions of Alzheimer's disease. J. Neurosci. Res. 30:673-681.
167. Narindrasorasak, S., Altman, R. A., Gonzalez-DeWhitt, P., Greenberg, B. D., and Kisilevsky, R. 1995. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. Lab. Invest. 72:272-282.